The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...
Study reveals a gap FDA approval AI radiology devices with only 29% undergoing clinical testing before clearance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback